Patents Assigned to Mor Research Applications
  • Publication number: 20190112665
    Abstract: Described herein are compositions and methods for the prediction of the prognosis of ovarian cancer subjects. The present invention further provides methods for distinguishing between histological subtypes of ovarian cancer tumors, and also methods and compositions for the treatment or prevention of ovarian cancer. Specifically the invention relates to microRNA molecules associated with said methods and compositions, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: May 9, 2018
    Publication date: April 18, 2019
    Applicants: ROSETTA GENOMICS LTD., MOR RESEARCH APPLICATIONS
    Inventors: Moshe Hoshen, Gila Lithwick Yanai, Ram Eitan
  • Patent number: 9988690
    Abstract: Described herein are compositions and methods for the prediction of the prognosis of ovarian cancer subjects. The present invention further provides methods for distinguishing between histological subtypes of ovarian cancer tumors, and also methods and compositions for the treatment or prevention of ovarian cancer. Specifically the invention relates to microRNA molecules associated with said methods and compositions, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: June 5, 2018
    Assignees: ROSETTA GENOMICS LTD., MOR RESEARCH APPLICATIONS
    Inventors: Moshe Hoshen, Gila Lithwick Yanai, Ram Eitan
  • Patent number: 9765334
    Abstract: Described herein are compositions and methods for survival prediction in gastric cancer patients after surgical operation. The compositions are microRNA molecules associated with the prognosis of gastric cancer, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: September 19, 2017
    Assignees: Rosetta Genomics, Ltd., Mor Research Applications
    Inventors: Moshe Hoshen, Raruch Brenner
  • Patent number: 9540695
    Abstract: Described herein are compositions and methods for the prediction of the prognosis of ovarian cancer subjects. The present invention further provides methods for distinguishing between histological subtypes of ovarian cancer tumors, and also methods and compositions for the treatment or prevention of ovarian cancer. Specifically the invention relates to microRNA molecules associated with said methods and compositions, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: January 10, 2017
    Assignees: Rosetta Genomics Ltd., MOR Research Applications
    Inventors: Moshe Hosen, Gila Lithwick Yanai, Ram Eitan
  • Patent number: 9334540
    Abstract: The present invention provides methods and compositions for identifying subjects at risk of developing a complication of pregnancy, such as preeclampsia or preterm labor. The compositions are microRNAs and associated nucleic acids.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: May 10, 2016
    Assignees: Rosetta Genomics Ltd., MOR Research Applications
    Inventors: Yaron Goren, Shlomit Gilad, Moshe Hod, Yariv Yogev
  • Publication number: 20140087967
    Abstract: The present invention provides methods and compositions for identifying subjects at risk of developing a complication of pregnancy, such as preeclampsia or preterm labor. The compositions are microRNAs and associated nucleic acids.
    Type: Application
    Filed: October 25, 2013
    Publication date: March 27, 2014
    Applicants: Mor Research Applications, Rosetta Genomics Ltd.
    Inventors: Yaron GOREN, Shlomit Gilad, Moshe Hod, Yariv Yogev
  • Patent number: 8580503
    Abstract: The present invention provides methods and compositions for identifying subjects at risk of developing a complication of pregnancy, such as preeclampsia or preterm labor. The compositions are microRNAs and associated nucleic acids.
    Type: Grant
    Filed: January 26, 2009
    Date of Patent: November 12, 2013
    Assignees: Rosetta Genomics Ltd., Mor Research Applications
    Inventors: Yaron Goren, Shlomit Gilad, Moshe Hod, Yariv Yogev